What is the usual dose of ceftriaxone (Ceftriaxone) for skin and tissue infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for Skin and Soft Tissue Infections

The recommended dose of ceftriaxone for skin and soft tissue infections is 1-2 grams once daily intravenously or intramuscularly for 5-7 days. 1

Dosing Guidelines

Adults:

  • Standard dose: 1-2 grams IV/IM once daily 1, 2
  • Maximum daily dose: Should not exceed 4 grams 2
  • Duration: Generally 5-7 days, but may be extended to 7-14 days for complicated infections 1, 3

Pediatric patients:

  • Standard dose: 50-75 mg/kg/day IV/IM given once daily (or in equally divided doses twice a day) 2
  • Maximum daily dose: Should not exceed 2 grams 2

Administration Routes

  • Intravenous: Administer over 30 minutes 2
  • Intramuscular: Inject well within the body of a relatively large muscle 2
    • For 1 gram dose: Reconstitute with 3.6 mL diluent for 250 mg/mL concentration or 2.1 mL for 350 mg/mL concentration 2

Clinical Evidence

Ceftriaxone has demonstrated excellent efficacy in treating skin and soft tissue infections with the convenience of once-daily dosing. Multiple studies have shown clinical cure rates of 81-89% for skin and soft tissue infections 4, 5. The long serum half-life of ceftriaxone allows for once-daily administration, providing a significant advantage over other antibiotics that require more frequent dosing 6.

Combination Therapy

For severe or necrotizing skin and soft tissue infections, broader coverage may be necessary:

  • For polymicrobial infections: Ceftriaxone 1 g every 24 hours + metronidazole 500 mg every 8 hours IV 1
  • For suspected MRSA: Consider adding vancomycin 15 mg/kg every 12 hours IV 1

Special Considerations

Renal/Hepatic Impairment

  • No dosage adjustment is necessary for patients with impairment of renal or hepatic function 2

Elderly Patients

  • No modification required for elderly patients, up to 2 grams per day, provided there is no severe renal and hepatic impairment 2

Contraindications

  • Hyperbilirubinemic neonates, especially prematures 2
  • Neonates (≤28 days) requiring calcium-containing IV solutions 2

Monitoring and Follow-up

  • Assess response to treatment within 48-72 hours 3
  • Watch for signs of abscess formation (fluctuance, persistent fever despite antibiotics) 3
  • If no improvement is seen within 24-48 hours of treatment, consider hospitalization or alternative therapy 3

Common Pitfalls to Avoid

  1. Calcium-containing solutions: Do not use diluents containing calcium (such as Ringer's solution or Hartmann's solution) to reconstitute ceftriaxone due to risk of precipitation 2
  2. Inadequate duration: Ensure complete course of therapy is administered, even if symptoms improve rapidly 3
  3. Missed coverage: For suspected polymicrobial infections, particularly those involving anaerobes, consider adding metronidazole 1
  4. Delayed treatment: Prompt initiation of appropriate antibiotic therapy is crucial to prevent complications 3

Ceftriaxone's once-daily dosing regimen offers excellent convenience while maintaining high efficacy for skin and soft tissue infections, making it a valuable option in both inpatient and outpatient settings.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Parotid Gland Infections Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Once-daily ceftriaxone for skin and soft tissue infections.

Antimicrobial agents and chemotherapy, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.